Items where Author is "Akhtari, J."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 16.

Article

Mehrad-Majd, H. and Akhtari, J. and Haerian, M. S. and Ravanshad, Y. (2019) Clinicopathological and prognostic value of lncRNA PANDAR expression in solid tumors: Evidence from a systematic review and meta-analysis. Journal of Cellular Physiology, 234 (4). pp. 4206-4216.

Mehrad-Majd, H. and Ravanshad, S. and Moradi, A. and Khansalar, N. and Sheikhi, M. and Akhtari, J. (2019) Decreased expression of lncRNA loc285194 as an independent prognostic marker in cancer: A systematic review and meta-analysis. Pathology Research and Practice, 215 (6).

Mehrad-Majd, H. and Haerian, M. S. and Akhtari, J. and Ravanshad, Y. and Azarfar, A. and Mamouri, G. (2019) Effects of Gly71Arg mutation in UGT1A1 gene on neonatal hyperbilirubinemia: a systematic review and meta-analysis. Journal of Maternal-Fetal and Neonatal Medicine, 32 (10). pp. 1575-1585.

Mehravaran, A. and Rezaei Nasab, M. and Mirahmadi, H. and Sharifi, I. and Alijani, E. and Reza Nikpoor, A. and Akhtari, J. and Hojatizade, M. (2019) Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice. Iranian Journal of Basic Medical Sciences, 22 (8). pp. 922-931.

Mehravaran, A. and Nasab, M. R. and Mirahmadi, H. and Sharifi, I. and Alijani, E. and Nikpoor, A. R. and Akhtari, J. (2019) Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis. Infection, Genetics and Evolution, 70. pp. 27-35.

Moosavian, S. A. and Abnous, K. and Akhtari, J. and Arabi, L. and Gholamzade Dewin, A. and Jafari, M. (2018) 5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells. Artificial Cells, Nanomedicine and Biotechnology, 46 (8). pp. 2054-2065.

Teymouri, M. and Karkhane, M. and Gilavand, F. and Akhtari, J. and Marzban, A. (2018) Extracellular Lipase Purification from a Marine Planomicrobium sp. MR23K and Productivity Optimization in a Pilot-Scale Submerged Bioreactor. Proceedings of the National Academy of Sciences India Section B - Biological Sciences, 88 (2). pp. 739-746.

Akhtari, J. and Tafazoli, A. and Mehrad-Majd, H. and Mahrooz, A. (2018) Nanovehicle-based small interfering rna (Sirna) delivery for therapeutic purposes: A new molecular approach in pharmacogenomics. Current Clinical Pharmacology, 13 (3). pp. 173-182.

Rezaieyazdi, Z. and Tabaei, S. and Ravanshad, Y. and Akhtari, J. and Mehrad-Majd, H. (2018) No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis. Clinical Rheumatology, 37 (6). pp. 1511-1519.

Shakeri, A. and Akhtari, J. and Soheili, V. and Taghizadeh, S. F. and Sahebkar, A. and Shaddel, R. and Asili, J. (2017) Identification and biological activity of the volatile compounds of Glycyrrhiza triphylla Fisch. & C.A.Mey. Microbial Pathogenesis, 109. pp. 39-44.

Teymouri, M. and Akhtari, J. and Karkhane, M. and Marzban, A. (2016) Assessment of phosphate solubilization activity of Rhizobacteria in mangrove forest. Biocatalysis and Agricultural Biotechnology, 5. pp. 168-172.

Alavizadeh, S. H. and Akhtari, J. and Badiee, A. and Golmohammadzadeh, S. and Jaafari, M. R. (2016) Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models. Expert Opinion on Drug Delivery, 13 (3). pp. 325-336.

Akhtari, J. and Rezayat, S. M. and Teymouri, M. and Alavizadeh, S. H. and Gheybi, F. and Badiee, A. and Jaafari, M. R. (2016) Targeting, bio distributive and tumor growth inhibiting characterization of anti-HER2 affibody coupling to liposomal doxorubicin using BALB/c mice bearing TUBO tumors. International Journal of Pharmaceutics, 505 (1-2). pp. 89-95.

Teymouri, M. and Badiee, A. and Golmohammadzadeh, S. and Sadri, K. and Akhtari, J. and Mellat, M. and Nikpoor, A. R. and Jaafari, M. R. (2016) Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity. International Journal of Pharmaceutics, 511 (1). pp. 236-244.

Teymouri, M. and Badiee, A. and Golmohammadzadeh, S. and Sadri, K. and Akhtari, J. and Mellat, M. and Nikpoor, A. R. and Jaafari, M. R. (2016) Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity. International Journal of Pharmaceutics, 511 (1). pp. 236-244.

Teymouri, M. and Badiee, A. and Golmohammadzadeh, S. and Sadri, K. and Akhtari, J. and Mellat, M. and Nikpoor, A. R. and Jaafari, M. R. (2016) Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity. International Journal of Pharmaceutics, 511 (1). pp. 236-244.

This list was generated on Thu Apr 22 15:26:53 2021 EDT.